REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 136 filers reported holding REVANCE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,709,000 | +72.6% | 63,279 | +56.1% | 0.45% | +2.0% |
| Q2 2020 | $990,000 | -39.2% | 40,541 | -63.1% | 0.44% | -53.3% |
| Q1 2020 | $1,627,000 | -26.5% | 109,939 | -19.4% | 0.95% | +7.4% |
| Q4 2019 | $2,214,000 | +60.1% | 136,443 | +203.9% | 0.89% | +23.6% |
| Q1 2018 | $1,383,000 | -13.8% | 44,898 | 0.0% | 0.72% | -12.8% |
| Q4 2017 | $1,605,000 | – | 44,898 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |